Introduction
============

Recently we have published a short and efficient protocol for the solid-phase synthesis of malondiamides leading to products of the general structure **1** ([Scheme 1](#molecules-10-01438-f002){ref-type="scheme"}) \[[@B1-molecules-10-01438]\]. The compounds obtained by exploiting this protocol show, in general, druglike properties and can be viewed at as retro-inverso surrogates of small peptide fragments.

Results and Discussion
======================

The preparation of the malondiamides **1** was performed with several preloaded resins (loading 0.30 -- 0.85 mmol/g) **2**, substituted malonyl dichlorides **3** and a diverse set of amines **5**. Among the amines used, a wide variety such as benzylamines, piperazines, and primary and secondary aliphatic amines could be reacted successfully.

![](molecules-10-01438-g002){#molecules-10-01438-f002}

Only amines with a high steric demand, such as diisopropylamine and *tert*-butylmethylamine or anilines afforded no product within two days reaction time at room temperature as judged by LC-MS after acid mediated cleavage. Because we planned to exploit this chemistry for the synthesis of split-and-mix libraries, it was pivotal that the formation of side-products via crosslinking between two resin bound amines by one molecule of diacid dichloride could be excluded. To apply this efficient protocol for the construction of more complex structures and to introduce a further point of diversity, it was envisaged to react the polymer-bound acid chlorides with bifunctional amines, which could be further derivatised with established nitrogen decorating chemistries. However, the use of unprotected piperazine **5a** ([Scheme 2](#molecules-10-01438-f003){ref-type="scheme"}, R^2^ = R^3^ = CH~2~CH~3~, n = 1) or homopiperazine **5b** (n = 2) gave only mixtures of the desired products **6** and the crosslinked *bis*-malonyl tetraamides **7** \[[@B2-molecules-10-01438]\]. These products could easily be separated and isolated by normal- or reverse-phase chromatography, but precluded this approach from being applied in a split-and-mix synthesis. Larger excesses of reagents and higher concentrations or the use of resins with lower loadings (\<0.2 mmol/g) did not significantly change the ratio of desired compounds to by-products.
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Not surprisingly, a complete different outcome was found when the same reactions were performed with mono-Boc-piperazine and mono-Boc-homopiperzine, respectively. The single product obtained after acid mediated cleavage were the expected malondiamides with the *tert*-butoxy carbonyl protecting group smoothly cleaved ([Scheme 3](#molecules-10-01438-f004){ref-type="scheme"}). During the studies to elaborate the scope and limitations of this protocol we have found that both, primary and secondary N'-Boc protected diamines, can successfully be acylated by the resin bound acid chloride ([Table 1](#molecules-10-01438-t001){ref-type="table"}). TFA mediated cleavage yielded the free amines in good to excellent purity as judged by HPLC and NMR. On-bead deprotection of the N'-Boc moiety was performed by established procedures (TMS-triflate, lutidine). The only drawback of this methodology was the incompatability with some ether functionalities (especially aliphatic methoxy ones) on the backbone amide \[[@B3-molecules-10-01438]\]. The free amines could then be decorated with established protocols such as sulfonylation ([Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 1-4) \[[@B4-molecules-10-01438]\], acylation ([Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 5,9) \[[@B5-molecules-10-01438]\], reductive amination ([table 2](#molecules-10-01438-t002){ref-type="table"}, entry 6) \[[@B6-molecules-10-01438]\], arylation ([Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 7) \[[@B7-molecules-10-01438]\] and urea-formation \[[@B8-molecules-10-01438]\] ([Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 8) \[[@B9-molecules-10-01438]\].

molecules-10-01438-t001_Table 1

###### 

Solid-phase synthesis of malonamides.

  --------------------------------------------------------------------------------------------------------------------------
  Entry   Compound   R~t~ ^a^                           Exact Mass\   Mass ^b^              Relative Peak Area(%) ^c^   
                                                        Formula                                                         
  ------- ---------- ---------------------------------- ------------- --------------------- --------------------------- ----
  **1**   **11**     ![](molecules-10-01438-i001.jpg)   3.05          385.43\               386.3                       94
                                                                      C~19~H~26~F~3~NO~2~                               

  **2**   **12**     ![](molecules-10-01438-i002.jpg)   3.27          329.45\               330.4                       93
                                                                      C~19~H~27~N~3~O~2~                                

  **3**   **13**     ![](molecules-10-01438-i003.jpg)   2.59          390.49\               391.6                       93
                                                                      C~20~H~30~N~4~O~4~                                

  **4**   **14**     ![](molecules-10-01438-i004.jpg)   2.22          348.41\               348.3                       92
                                                                      C~17~H~24~N~4~O~4~                                

  **5**   **15**     ![](molecules-10-01438-i005.jpg)   6.75          339.44\               340.5                       92
                                                                      C~20~H~25~N~3~O~2~                                
  --------------------------------------------------------------------------------------------------------------------------

\(a\) Retention time (minutes), column: Prontosil 120-3-C18, 4.3 mm x 53 mm; 3 µm; 1.5 mL/min; 15-min gradient from 100% aqueous media (0.1% TFA) to 100% CH3CN (0.1% TFA). (b) LC-MS: EI-positive mode (c) Relative peak area by HPLC based on UV absorption at 214 nm.

Experimental conditions were refined to reach after cleavage suitable purity for biological testing without further purification. It was found crucial for this approach that the first acylation of the backbone-nitrogen must be complete or otherwise by-products are formed. Purity and identity were checked by LC-MS and HPLC. Representative compounds were subjected to spectroscopic characterization, in addition, some of the products were crystalline and have been submitted to x-ray analysis to obtain experimental data about (solid-state) conformations (e.g. [Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 3). A more extensive exploitation of this protocol\`s diversity potential was achieved by repetition of the procedure. ([Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 9) As an example **27** could be obtained by acidic cleavage in moderate purity after deprotection, subsequent acylation with dimethylmalonyl dichloride and trapping with 1-(4-methoxy-phenyl)-piperazine. The impurities found in this case could be assigned to fragments derived from incomplete acylation and partial loss of the methoxy ether moiety during the Boc deprotection process.
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molecules-10-01438-t002_Table 2

###### 

Solid-phase synthesis of malonamides.

  ----------------------------------------------------------------------------------------------------------------------------------
  Entry   Compound     R~t~ ^a^                           Exact Mass\   Mass ^b^                   Relative Peak Area(%) ^c^   
                                                          Formula                                                              
  ------- ------------ ---------------------------------- ------------- -------------------------- --------------------------- -----
  **1**   **19**       ![](molecules-10-01438-i006.jpg)   5.90          580.71\                    581.4                       96
                                                                        C~30~H~36~N~4~O~6~S                                    

  **2**   **20**       ![](molecules-10-01438-i007.jpg)   5.67          538.63\                    539.4                       95
                                                                        C~27~H~30~N~4~O~6~S                                    

  **3**   **21 ^d^**   ![](molecules-10-01438-i008.jpg)   6.13          545.66\                    546.5                       92
                                                                        C~27~H~35~N~3~O~7~S                                    

  **4**   **22**       ![](molecules-10-01438-i009.jpg)   6.65          519.67\                    520.5                       94
                                                                        C~29~H~33~N~3~O~4~S                                    

  **5**   **23**       ![](molecules-10-01438-i010.jpg)   6.39          509.65\                    510.4                       93
                                                                        C~32~H~35~N~3~O~3~                                     

  **6**   **24**       ![](molecules-10-01438-i011.jpg)   4.89          447.63\                    448.4                       93
                                                                        C~28~H~37~N~3~O~2~                                     

  **7**   **25**       ![](molecules-10-01438-i012.jpg)   8.27          644.10\                    644.4\                      100
                                                                        C~32~H~33~ClF~3~N~5~O~4~   646.5                       

  **8**   **26**       ![](molecules-10-01438-i013.jpg)   5.92          476.62\                    477.7                       94
                                                                        C~28~H~36~N~4~O~3~                                     

  **9**   **27**       ![](molecules-10-01438-i014.jpg)   7.67          663.86\                    664.5                       69
                                                                        C~37~H~53~N~5~O~6~                                     
  ----------------------------------------------------------------------------------------------------------------------------------

\(a\) Retention time (minutes), column: Prontosil 120-3-C18, 4.3 mm × 53 mm; 3 µm; 1.5 mL/min; 15-min gradient from 100% aqueous media (0.1% TFA) to 100% CH~3~CN (0.1% TFA). (b) LC-MS: EI-positive mode (c) Relative peak area by HPLC based on UV absorption at 214 nm (d) The characterization of this compound could be supported by x-ray crystallography.

The validity of this protocol was exemplified by the preparation of a small split-and-and-mix library ([Figure 1](#molecules-10-01438-f001){ref-type="fig"}). Five preloaded resins (loading 0.30 -- 0.85 mmol/g) were thoroughly mixed and reacted with dimethyl malonyl dichloride, carefully washed and quenched with Boc-piperazine. The resin was deprotected and acylated with 4-nitrobenzoyl chloride. LC-MS and HPLC analysis of the cleaved mixture showed good purity (\> 96% of the total UV-trace area at 214 nm) and identity.

![LC-MS (EI-positive mode) of mixture of **30a-e**.](molecules-10-01438-g001){#molecules-10-01438-f001}

Conclusions
===========

The approach presented here is a robust and efficient protocol for the synthesis of the title compounds. The preparation of the malondiamides was performed with a variety of resins and several diamines. The polymer bound intermediates can be further reacted with established nitrogen decorating techniques to introduce further diversity.

Experimental
============

^1^H-NMR and ^13^C-NMR were run at 400 MHz and 125 MHz, respectively, on a Bruker AM 400 spectrometer (^1^H-NMR) using TMS as internal standard. The spectra were recorded at room temperature. Compounds that form diastereomeric rotamers can give rise to complex spectra. LC-MS spectra were recorded on an Agilent HP1100 LC / Waters ZQ-2000 system (Prontosil 120-3-C18) at 70 eV.

General Procedure
-----------------

BAL-resin (**2**, 200 mg) was washed with 5:1 DCM/DIPEA, then the dialkyl malonyl dichloride (**3**, 10 equivalents) was added in 4:1 DCM/DIPEA (3 mL) and the mixture was shaken for 12 h. The resin was washed three times with 4:1 DCM/DIPEA, then the mono-Boc diamine (10 equivalents) in 4:1 DCM/DIPEA (3 mL) was added and shaken at RT overnight. The resin was filtered off and then washed with DCM, DMA and finally MeOH. BOC deprotection was performed by shaking the resin twice with 1 M TMSOTf (3 mL) and 1.5 M 2,6-1utidine in DCM (2 x 30 min). The resin was washed several times with DCM, DMA and finally MeOH. The resin was subjected to N-derivatisation and then washed again (DCM, DMA, MeOH). The resin was dried and then treated twice with TFA ~95%~/DCM (1:4). Evaporation of the solvents yielded the products. Selected examples were purified by flash chromatography for analytical reasons.

*2-Ethyl-2-(piperazine-1-carbonyl)-N-(4-trifluoromethyl-benzyl)-butyramide* (**11**, [Table 1](#molecules-10-01438-t001){ref-type="table"}, entry 1): Colorless oil, contains TFA. No further purification. ^1^H-NMR (CD~3~OD): δ = 7.69 (2 H, d, J = 9.1 Hz), 7.55 (2 H, d, J = 9.1 Hz), 4.35 (2 H, s), 3.50 -- 3.70 (4 H, s, broad), 2.80 -- 2.00 (4 H, s, broad), 1.90 (2 H, m), 1.75 (2 H, m), 0.70 (6 H, m); ^13^C-NMR (CD~3~OD): δ = 175.6, 173.8, 145.1, 131.5, 131.2, 130.9, 130.5(q), 130.0, 126.9, 123.0, 119.1, 116.2, 113.3(q), 60.4, 44.4, 44.2, 38.9, 26.9, 9.1.

*N-(2,3-Dihydro-benzo\[1,4\]dioxin-2-ylmethyl)-2-ethyl-2-\[4-(4-methoxy-benzenesulfonyl)-piperazine-1-carbonyl\]-butyramide* (**21**, [Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 3): Colorless crystals, 92% crude purity (HPLC-214 nm), 93% crude yield, 76% isolated yield after flash chromatography. R~f~ = 0.22 (1:1 hexane/ethylacetate); λ~max~ = 242 nm; ^1^H-NMR (DMSO-D~6~): δ = 7.90 (m, 1H), 7.56 (2 H, d, J = 6.9), 7.05 (2 H, d, J = 6.9), 6.77 -- 6.90 (4 H, m), 4.22 (1 H, m), 4.12 (1 H, m), 3.87 (1 H, m), 3.79 (3 H, s), 3.40 -- 3.53 (4 H, s), 3.17 -- 3.24 (2 H, m), 2.70 -- 2.85 (4 H, s), 1.60 -- 1.80 (4 H, m), 0.61 (6 H, t); ^13^C-NMR (DMSO-D~6~): δ = 172.8, 169.11, 162.9, 142.9, 142.6, 129.83, 125.9, 121.5, 121.3, 117.1, 116.9, 114.5, 71.48, 71.1, 65.7, 56.6, 55.7, 45.5, 24.5, 8.00.

*2-\[4-(1-Phenethylcarbamoyl-cyclobutanecarbonyl)-\[1,4\]diazepan-1-yl\]-4-trifluoromethyl-pyrimidine-5 carboxylic acid 4-chloro-benzyl ester* (**25**, [Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 7): Colorless crystals, 100% crude purity (HPLC-214 nm), 88% crude yield, 82% isolated yield after flash chromatography. Mixture of rotamers at room temperature. R~f~ = 0.45 (2:1 hexane/ethylacetate); λ~max~ = 281 nm; ^1^H-NMR (DMSO-D~6~): δ = 8.99 (1 H, s), 7.03 -- 7.48 (9 H, m), 5.28 (2 H, m), 3.52 - 3.95 (6 H, m), 3.08 - 3.25 (4 H, m), 2.75 (2 H, m), 2.30 -2.42 (4 H, m), 1.61 -- 1.70 (4 H, m); ^13^C NMR (DMSO-D~6~): δ = 182.3, 177.7, 170.9, 170.7, 163.0, 162.6 (q), 153.9, 139.4, 134.7, 132.8, 130.0, 128.5, 128.2, 126.2, 119.5 (q), 109.8, 65.8, 55.0, 53.33, 47.8, 46.0, 45.7, 49.3, 34.8, 28.8, 27.3, 25.1, 15.0.

*4-(1-Phenethylcarbamoyl-cyclobutanecarbonyl)-\[1,4\]diazepane-1-carboxylic acid (3,5-dimethyl-phenyl) amide* (**26**, [Table 2](#molecules-10-01438-t002){ref-type="table"}, entry 8): Colorless crystals, 94% crude purity (HPLC-214 nm), 78% crude yield, 71% isolated yield after flash chromatography. Mixture of rotamers at room temperature. R~f~ = 0.24 (2:1 hexane/ethylacetate); λ~max~ = 244 nm; ^1^H-NMR (DMSO-D~6~): δ = 7.52 (2 H, m), 7.08 -- 7.27(5 H, m), 6.56 (1 H, d), 3.15 -- 3.57 (10 H, m), 2.70 (3 H, m), 2.30 (3 H, m), 2.19 (2 H, m), 1.74 (2 H, m), 1.64 (4 H, m), 1.53 (2 H, m);^13^C-NMR (DMSO-D~6~): δ = 171.5, 170.7, 154.8, 140.4, 140.2, 139.44, 137.0, 128.7, 128.3, 126.0, 123.4, 123.2, 117.8, 54.0, 53.3, 47.5, 47.2, 46.9, 46.0, 40.5, 34.9, 29.1, 26.3, 21.1, 15.4.

We thank Werner Breitenstein, Philipp Grosche and Jürg Zimmermann for helpful discussions, Trixi Wagner for x-ray analyses and Susanne Osswald for help with NMR-characterization.

*Sample availability*: Contact the authors
